Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. - Lesley Jones; Darlene R. Goldstein; Gareth P. Hughes; Andrew Strand; François Collin; Stephen B. Dunnett; Charles L. Kooperberg; Aaron Aragaki; James M. Olson; Sarah J. Augood; Richard L. M. Faull; Ruth Luthi-Carter; et al. (BMC Bioinform., 2006)

DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma. - Carlo Giussani; Andrew V. Poliakov; Raymond T. Ferri; Lauren L. Plawner; Samuel R. Browd; Dennis W. W. Shaw; Tanya Z. Filardi; Corrine Hoeppner; J. Russell Geyer; James M. Olson; James G. Douglas; Elisabeth H. Villavicencio; et al. (NeuroImage, 2010)

Accurate de novo design of hyperstable constrained peptides. - Gaurav Bhardwaj; Vikram Khipple Mulligan; Christopher D. Bahl; Jason M. Gilmore; Peta J. Harvey; Olivier Cheneval; Garry W. Buchko; Surya V. S. R. K. Pulavarti; Quentin Kaas; Alexander Eletsky; Po-Ssu Huang; William A. Johnsen; et al. (Nat., 2016)

Laboratory information management software for engineered mini-protein therapeutic workflow. - Mi-Youn K. Brusniak; Hector Ramos; Bernard Lee; James M. Olson (BMC Bioinform., 2019)